Schiff Hardin advised the underwriter on the deal.Unicycive Therapeutics (NASDAQ:UNCY) has priced its IPO of 5M units at $5.00/unit, for expected gross proceeds are $25M. Each…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
